Background: Diabetic nephropathy is the leading cause of end-stage chronic kidney disease with poor prognosis in resource-limited settings. This study aimed to determine factors associated with mortality in patients starting dialysis treatment for end-stage chronic renal disease in an emergency context. Patients and Methods: This was a retrospective study from January 2020 to December 2022 at CHU-B. Data from 79 diabetic patients requiring emergency dialysis were compared with those of 79 non-diabetic patients with an end-stage renal disease requiring emergency dialysis. Data were collected from the Nephrology Department registry. We studied their initial clinical and biological profiles and factors related to mortality. Results: Out of 545 compiled records, 79 diabetic chronic kidney disease patients needing dialysis were included (group 1). A control group of 79 non-diabetic chronic kidney disease patients requiring emergency dialysis was also included (group 2). The average age of patients was 53.5 ± 17 years, and the duration of diabetes at dialysis initiation was 14.8 ± 4.3 years. Twenty-three percent were hypertensive. Fifty-two percent of patients experienced intra-dialytic hypotension. Death occurred in 22% of patients. Results show that age (adjusted OR 1.955; CI: 1.025 - 1.086; p-value: < 0.001) and intra-dialytic hypotension (adjusted OR 2.412; CI: 1.901 - 2.201; p-value: < 0.001) are independent and significant risk factors for mortality in diabetic patients admitted with end-stage renal disease requiring emergency dialysis. Conclusion: Emergency dialysis in diabetics is associated with unfavorable outcomes in terms of mortality. Despite follow-up, renal involvement remains poorly explored, emphasizing the need for physician awareness.
References
[1]
Bouenizabila, E., Loumingou, R., Motoula, M., Andzouana, N. and Monabeka, H.G. (2015) Diabetic Nephropathy at Brazzaville University Hospital, Congo: Epidemiological and Clinical Aspects, and Risk Factors. Médecine des Maladies Métaboliques, 9, 220-226. https://doi.org/10.1016/S1957-2557(15)30048-1
Fineberg, D., Jandeleit-Dahm, K.A.M. and Cooper, M.E. (2013) Diabetic Nephropathy: Diagnosis and Treatment. Nature Reviews Endocrinology, 9, 713-723. https://doi.org/10.1038/nrendo.2013.184
[4]
Evans, K., Pyart, R., Steenkamp, R., Whitlock, T., Stannard, C., Gair, R., et al. (2023) UK Renal Registry 20th Annual Report: Introduction. http://www.karger.com/Services/OpenAccessLicense
[5]
Koye, D.N., Shaw, J.E., Reid, C.M., Atkins, R.C., Reutens, A.T. and Magliano, D.J. (2017) Incidence of Chronic Kidney Disease among People with Diabetes: A Systematic Review of Observational Studies. Diabetic Medicine, 34, 887-901. https://doi.org/10.1111/dme.13324
[6]
Perkins, B.A., Ficociello, L.H., Silva, K.H., Finkelstein, D.M., Warram, J.H. and Krolewski, A.S. (2003) Regression of Microalbuminuria in Type 1 Diabetes. The New England Journal of Medicine, 348, 2285-2293. https://doi.org/10.1056/NEJMoa021835
[7]
(2022) Annual Data Report | USRDS. https://usrds-adr.niddk.nih.gov/2022
[8]
Olié, V., Cheddani, L., Stengel, B., Gabet, A., Grave, C., Blacher J., et al. (2021) Prevalence of Chronic Kidney Disease in France, Esteban Study 2014-2016. Néphrologie & Thérapeutique, 17, 526-531. https://doi.org/10.1016/j.nephro.2021.05.006
[9]
Ritz, E., Rychlik, I., Locatelli, F. and Halimi, S. (1999) End-Stage Renal Failure in Type 2 Diabetes: A Medical Catastrophe of Worldwide Dimensions. American Journal of Kidney Diseases, 34, 795-808. https://doi.org/10.1016/S0272-6386(99)70035-1
[10]
Cao, P., Huang, B., Hong, M., Jiang, Y., Cao, R., Chi, C., et al. (2022) Association of Amino Acids Related to Urea Cycle with Risk of Diabetic Nephropathy in Two Independent Cross-Sectional Studies of Chinese Adults. Frontiers in Endocrinology, 13, Article ID: 983747. https://doi.org/10.3389/fendo.2022.983747
[11]
Sinomono, D.T.E., Loumingou, R., Koumou, G.C.G., Mahoungou, G.H. and Mobengo, J.L. (2021) Chronic Renal Failure in the Brazzaville University Hospital Center: Epidemiological, Clinical and Evolutionary Aspects. Saudi Journal of Kidney Diseases and Transplantation, 32, 1450-1455.
[12]
Kowalski, A., Krikorian, A. and Lerma, E.V. (2014) Diabetic Nephropathy for the Primary Care Provider: New Understandings on Early Detection and Treatment. Ochsner Journal, 14, 369.
[13]
Vijayan, M., Radhakrishnan, S., Abraham, G., Mathew, M., Sampathkumar, K. and Mancha, N.P. (2016) Diabetic Kidney Disease Patients on Hemodialysis: A Retrospective Survival Analysis across Different Socioeconomic Groups. Clinical Kidney Journal, 9, 833-838. https://doi.org/10.1093/ckj/sfw069
[14]
Disease, K. and Global Outcomes Diabetes Work Group (2022) KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney International, 102, S1-127. https://doi.org/10.1016/j.kint.2022.06.008
[15]
Sundqvist, H., Heikkala, E., Jokelainen, J., Russo, G., Mikkola, I. and Hagnäs, M. (2022) Association of Renal Function Screening Frequency with Renal Function Decline in Patients with Type 2 Diabetes: A Real-World Study in Primary Health Care. BMC Nephrology, 23, 1-8. https://doi.org/10.1186/s12882-022-02979-1
[16]
Zemmouchi, S. (2022) The Specifics of Hemodialysis in Diabetes East Algerian Experience. Journal of Hypertension, 40, e184. https://doi.org/10.1097/01.hjh.0000837272.34131.03
[17]
Shoji, T., Tsubakihara, Y., Fujii, M. and Imai, E. (2004) Hemodialysis-Associated Hypotension as an Independent Risk Factor for Two-Year Mortality in Hemodialysis Patients. Kidney International, 66, 1212-1220. https://doi.org/10.1111/j.1523-1755.2004.00812.x